United Therapeutics Announces Details on Phase Two of its Restrict Contract Pharmacy Policy
By letter dated April 12, drug manufacturer United Therapeutics (UT) announced additional details regarding the second phase of its restrictive contract pharmacy policy. UT initially sent letters to covered entities in November 2020 notifying them that UT would be implementing a new contract pharmacy policy in two phases. Under the first phase, UT stated that it will deny all…